These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8907208)

  • 1. Program on the surgical control of the hyperlipidemias: 1994 report.
    Buchwald H; Campos CT
    J Cardiovasc Pharmacol; 1995; 25 Suppl 4():S3-10. PubMed ID: 8907208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall mortality, incremental life expectancy, and cause of death at 25 years in the program on the surgical control of the hyperlipidemias.
    Buchwald H; Rudser KD; Williams SE; Michalek VN; Vagasky J; Connett JE
    Ann Surg; 2010 Jun; 251(6):1034-40. PubMed ID: 20485136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Varco RL; Boen JR; Williams SE; Hansen BJ; Campos CT; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD; Sawin HS
    Arch Intern Med; 1998 Jun; 158(11):1253-61. PubMed ID: 9625405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Program on the Surgical Control of the Hyperlipidemias: a status report.
    Buchwald H; Moore RB; Matts JP; Long JM; Varco RL; Campbell GS; Pearce MB; Yellin AE; Blankenhorn DH; Holmes WL; Smink RD; Sawin HS
    Surgery; 1982 Oct; 92(4):654-62. PubMed ID: 6750834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-free intervals after partial ileal bypass in patients with coronary heart disease and hypercholesterolemia: report from the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Campos CT; Boen JR; Nguyen PA; Williams SE
    J Am Coll Cardiol; 1995 Aug; 26(2):351-7. PubMed ID: 7608434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias.
    Buchwald H; Campos CT; Matts JP; Fitch LL; Long JM; Varco RL
    Ann Surg; 1992 Oct; 216(4):389-98; discussion 398-400. PubMed ID: 1417188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
    Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
    Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of number of vessels disease on outcome of patients with stable coronary artery disease: 5-year follow-up of the Medical, Angioplasty, and bypass Surgery study (MASS).
    Lopes NH; Paulitsch Fda S; Gois AF; Pereira AC; Stolf NA; Dallan LO; Ramires JA; Hueb WA
    Eur J Cardiothorac Surg; 2008 Mar; 33(3):349-54. PubMed ID: 18249128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study.
    Koren MJ; Hunninghake DB;
    J Am Coll Cardiol; 2004 Nov; 44(9):1772-9. PubMed ID: 15519006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Program on the Surgical Control of the Hyperlipidemias (POSCH): patient entry characteristics. The POSCH Group.
    Matts JP; Buchwald H; Fitch LL; Campos CT; Varco RL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    Control Clin Trials; 1991 Apr; 12(2):314-39. PubMed ID: 1645643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of low high-density lipoprotein cholesterolemia induced by probucol on the progression of coronary atherosclerosis].
    Takahashi T; Hiasa Y; Harada S; Hosokawa S; Kato S; Tanimoto M; Kishi K; Ohtani R
    J Cardiol; 1997 Aug; 30(2):67-72. PubMed ID: 9300286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active Lipid Management In Coronary Artery Disease (ALMICAD) study.
    Khanal S; Obeidat O; Hudson MP; Al-Mallah M; Bloome M; Lu M; Greenbaum AB; Kugelmass AD; Weaver WD
    Am J Med; 2007 Aug; 120(8):734.e11-7. PubMed ID: 17679135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Symeonidis AN; Daskalopoulou SS; Kakafika AI; Pehlivanidis AN; Bouloukos VI; Langer A;
    Curr Med Res Opin; 2004 Sep; 20(9):1385-92. PubMed ID: 15383187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. Twenty-year clinical outcome.
    van Domburg RT; Foley DP; Breeman A; van Herwerden LA; Serruys PW
    Eur Heart J; 2002 Apr; 23(7):543-9. PubMed ID: 11922644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.